Abstract:
Objective: To evaluate the clinical efficacy and safety of bronchial artery embolization(BAE) by using new embolic material Embosphere microspheres in treating massive hemoptysis in advanced lung cancer.
Methods: During the period from Jan.2013 to Jan.2016, a total of fourteen advanced lung cancer patients with hemoptysis who had failed in clinical regimen, received BAE. The BAE was performed massive with Embosphere microspheres in all patients. All patients were followed up for more than 3 months with no complications observed.
Results: Complete cessation of bleeding was seen in 8 cases (57.1%), non-complete cessation in 4 cases (28.6%), failed cessation in 2 cases (14.3%), with a total success rate of 85.7%. Postoperative recurrence within 3 months was seen in one case (dead), over 3 months in 2 cases. There were no severe complications occurred in all patients.
Conclusions: For massive hemoptysis in advanced lung cancer, BAE with Embosphere microsphere is a simple, safe and effective strategy which has less complication occurrence and lower recurrent rate. Thus, it deserves a wide application in clinics.
Key words:
Lung cancer,
Hemoptysis,
Endovascular embolization,
Interventional therapy,
Embosphere microspheres
Cheng Li, Changsheng Shi, Xixiang Yu, Shuting Wang, Binbin Qiao, Guoqing Zhu, Zhenjing Shi, Bingru Zheng. Evaluation on the efficacy of the target-vessel embolization with Embosphere microspheres for the treatment of massive haemoptysis in advanced lung cancer[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2016, 04(03): 155-157.